Type
. Analysis of B-cell epitopes in the variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein. Infection and immunity. 1993;61(1):135-41.
Type
. [Differential diagnosis leprosy]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1978;29(3):160-2.
Type
. Involvement of the gastrointestinal tract in leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 1978;46(1):35-41. Available from: http://ila.ilsl.br/pdfs/v46n1a06.pdf
Type
. Effect of rifampin, clofazimine, and B1912 on the viability of Mycobacterium leprae in established mouse footpad infection. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). 1976;151(4):637-41.
Type
. Recent advances in the immunology of leprosy. International journal of dermatology. 1976;15(3):157-70.
Type
. Leprosy: "loathsome disease in Tracadie, New Brunswick"--a flimpse into the past century. Canadian Medical Association journal. 1976;114(5):440-2.
Type
. Obituary: Dr Vincent C. Barry. Leprosy review [Internet]. 1976;47(1):63-4. Available from: http://leprev.ilsl.br/pdfs/1976/v47n1/pdf/v47n1a14.pdf
Type
. Susceptibility of Mycobacterium leprae to dapsone as a determinant of patient response to acedapsone. Antimicrobial agents and chemotherapy. 1976;9(1):102-12.
Type
. Anergy and infection. Advances in internal medicine. 1976;21:149-73.
Type
. Lymphocyte transformation using Mitsuda antigen (lepromin). The Journal of dermatology. 1975;2(4):175-8.